Development of a chimeric recombinant disintegrin as a cost-effective anticancer agent with promising translational potential

Por Minea, Radu, Helchowski, Corey, Rubino, Barbara, Brodmann, Kyle, Swenson, Stephen, Markland, Francis
Publicado em 2011

Rare Stochastic Expression of O6-Methylguanine- DNA Methyltransferase (MGMT) in MGMT-Negative Melanoma Cells Determines Immediate Emergence of Drug-Resistant Populations upon Treat...

Por Chen, Thomas C., Chan, Nymph, Minea, Radu O., Hartman, Hannah, Hofman, Florence M., Schönthal, Axel H.
Publicado no Cancers (Basel) (2018)

A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice

Por Swenson, Steve, Minea, Radu O., Tuan, Cao Duc, Thein, Thu-Zan, Chen, Thomas C., Markland, Francis S.
Publicado no Molecules (2018)

Vicrostatin – An Anti-Invasive Multi-Integrin Targeting Chimeric Disintegrin with Tumor Anti-Angiogenic and Pro-Apoptotic Activities

Por Minea, Radu O., Helchowski, Corey M., Zidovetzki, Samuel J., Costa, Fritz K., Swenson, Stephen D., Markland, Francis S.
Publicado em 2010

Cytotoxic impact of a perillyl alcohol–temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma in vitro

Por Silva-Hirschberg, Catalina, Hartman, Hannah, Stack, Samantha, Swenson, Steve, Minea, Radu O., Davitz, Michael A., Chen, Thomas C., Schönthal, Axel H.
Publicado no Ther Adv Med Oncol (2019)

Multimeric Disintegrin Protein Polymer Fusions That Target Tumor Vasculature

Por Janib, Siti M., Gustafson, Joshua A., Minea, Radu O., Swenson, Stephen D., Liu, Shuanglong, Pastuszka, Martha K., Lock, Lye Lin, Cui, Honggang, Markland, Francis S., Conti, Peter S., Li, Zibo, MacKay, J. Andrew
Publicado em 2014